January 2015: A federal judge granted the parties’ joint motion for dismissal. The reasons for the dismissal have not yet been disclosed.
February 2014: A false advertising class-action lawsuit alleging that Walgreens misleadingly labels its Ear Pain Relief and Ear Ache Drops (a homeopathic medicine) was transferred from state court to federal court. The complaint, which was originally filed in 2013, alleges that the products’ labels represent that the ear drops will relieve ear pain when they actually do not work as advertised and the products’ labels violate FDA regulations. (Demison et al v. Walgreen Co. Inc. and Does 1-20, Case No. 14-cv-0306, S. D. CA.).
For more information about other class-action lawsuits regarding homeopathic medications and TINA.org’s coverage of the topic, click here.
Allegations: Misleadingly marketing that products boost free testosterone levels, increase lean muscle mass, strength, and endurance, and improve sexual function in men when none of the ingredients provide the advertised…
Allegations: Falsely advertising the accuracy of ovulation test kits
Allegations: Falsely marketing that products contain no preservatives when they contain preservative ingredients
Allegations: Marketing products as safe without disclosing that they are contaminated with the carcinogen benzene
Allegations: Failing to disclose products contain the carcinogen benzene
Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene
Allegations: Falsely marketing products as recyclable
Allegations: Misleadingly marketing that products are dishwasher safe and heavy duty
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely advertising sunscreens as waterproof
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that medicines relieve sinus pressure and congestion
Allegations: Falsely marketing medicines as treats nasal congestion
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing products as decongestants
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that products treat symptoms of pink eye
Allegations: Falsely marketing that medicines treat nasal decongestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing the product as a “treatment” for minor cuts and abrasions without scientific evidence to support such claims
Allegations: Misleadingly marketing products as if they are more suitable for children when they contain the same formulation as the adult version
Allegations: Falsely marketing products as “Non-Drowsy”
Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children
Allegations: Misleadingly marketing pain relieving lidocaine patches
Allegations: Failing to disclose that products may contain a dangerous substance that increases the risk of serious adverse health consequences and death
Allegations: Failing to disclose that products contain a harmful substance and may increase the risk of contracting invasive infections
Allegations: Marketing products as ordinary cigarettes when menthol cigarettes are more dangerous and addictive than other types of cigarettes
Allegations: Misleadingly marketing lidocaine pain relieving patches
Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…
Allegations: Misleadingly marketing products as “Maximum Strength” when other products deliver more lidocaine
Allegations: Misleadingly marketing medicines as “non-drowsy” when the active ingredient in them causes drowsiness
Allegations: Falsely marketing products as “fast-release” when they do not work faster than other products marketed as “fast-release”
Allegations: Falsely marketing that the tablets do not contain gelatin when they contain a “notable” amount of gelatin
Several store-brand aloe vera gels lack the acclaimed soothing ingredient.
Final Agreement Bans Deceptive Claims Made by Walmart, Walgreens & Supervalu MADISON, CONN. March 25, 2015 — A federal judge has given final approval to a class-action settlement that permanently changes how…
Federal judge approves revised class-action settlement terms following TINA.org objection to original proposal.
TINA.org, continuing its efforts to oppose unfair settlements, files an objection.
State officials demand Walmart, Target, Walgreens and GNC stop selling the supplements.